BURCAR ALISON D 4
4 · ICU MEDICAL INC/DE · Filed Jun 20, 2018
Insider Transaction Report
Form 4
BRUMMETT BURCAR ALISON
Vice President Marketing
Transactions
- Sale
Common Stock
2018-06-18$302.75/sh−5,735$1,736,271→ 4,174 total - Exercise of In-Money
Common Stock
2018-06-18$58.79/sh+17,108$1,005,779→ 21,311 total - Sale
Common Stock
2018-06-18$304.73/sh−412$125,549→ 17,399 total - Sale
Common Stock
2018-06-18$305.90/sh−191$58,427→ 17,108 total - Sale
Common Stock
2018-06-19$301.84/sh−26,973$8,141,530→ 5,274 total - Exercise of In-Money
Common Stock
2018-06-20$58.79/sh+21,169$1,244,526→ 21,169 total - Sale
Common Stock
2018-06-20$300.73/sh−5,294$1,592,065→ 15,875 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-19−34,747→ 23,145 totalExercise: $58.79Exp: 2024-02-24→ Common Stock (34,747 underlying) - Sale
Common Stock
2018-06-18$305.90/sh−100$30,590→ 17,299 total - Sale
Common Stock
2018-06-18$301.56/sh−7,199$2,170,930→ 9,909 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-18−17,108→ 57,892 totalExercise: $58.79Exp: 2024-02-24→ Common Stock (17,108 underlying) - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-20−21,169→ 1,976 totalExercise: $58.79Exp: 2024-02-24→ Common Stock (21,169 underlying) - Sale
Common Stock
2018-06-18$304.16/sh−1,800$547,488→ 17,811 total - Sale
Common Stock
2018-06-18$303.40/sh−1,977$599,822→ 2,197 total - Sale
Common Stock
2018-06-18$304.65/sh−2,197$669,316→ 0 total - Sale
Common Stock
2018-06-19$302.27/sh−5,274$1,594,172→ 0 total - Sale
Common Stock
2018-06-20$302.50/sh−2,125$642,813→ 0 total - Exercise of In-Money
Common Stock
2018-06-19$58.79/sh+34,747$2,042,776→ 34,747 total - Sale
Common Stock
2018-06-19$300.20/sh−2,500$750,500→ 32,247 total - Sale
Common Stock
2018-06-20$301.66/sh−13,750$4,147,825→ 2,125 total - Sale
Common Stock
2018-06-18$302.93/sh−1,700$514,981→ 19,611 total
Footnotes (17)
- [F1]These securities are Restricted Stock Units.
- [F10]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.15 to $305.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F11]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.55, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F12]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.10 to $302.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F13]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.13 to $302.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F14]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $300.20 to $301.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F15]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.30 to $302.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F16]Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
- [F17]Transaction is the exercise of a derivative security; see Column 2.
- [F2]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.50 to $303.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.55 to $304.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F4]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $304.60 to $304.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F5]All shares sold were sold at the exact price disclosed.
- [F6]Shares were previously acquired through the Registrant's Employee Stock Purchase Plan.
- [F7]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F8]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.05 to $303.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F9]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.10 to $304.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.